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ABSTRACT WE-14 is generated in subpopulations of chromogranin A immunopositive endo-
crine cells and neurons including those innervating the anterior uvea. This study investigated
WE-14 in intact sclero-limbo-corneal tissue from embryonic (E17), neonatal (N0-N16), and adult
mice using immunocytochemistry and confocal scanning laser microscopy. Weak WE-14 immuno-
staining was observed at birth in nerve ﬁbre tracts entering the corneal mid-stroma from the
limbo-scleral junction. Immunopositive ﬁbre tracts were evident throughout the cornea at N3; by
N5 the mid-stromal plexus had begun to generate ﬁbre populations extending toward the develop-
ing corneal epithelium, and some varicose ﬁbres terminated amongst the developing epithelium.
Immunostaining was evident at N7 in the developing limbo-scleral nerve net and some ﬁbres
exhibited a close association with unidentiﬁed vascular elements. By N11 and in subsequent
neonates, the cornea had developed a distinct stratiﬁed nerve net composed of thick mid-stromal
and thinner upper stromal nerve ﬁbre bundles; both possessed populations of varicose WE-14
immunopositive ﬁbres. In the adult, a sub-epithelial network of varicose WE-14 immunopositive
ﬁbres were evident at the limbo-scleral junction. Some ﬁbres exhibited a close association with
unidentiﬁed vascular elements, while others extended into the upper peripheral corneal stroma.
WE-14 was evident in leashes throughout the basal corneal epithelium and generated ﬁbres
ramifying between the stratiﬁed epithelium with some ﬁbres terminating amongst the outermost
corneal epithelia. This study has demonstrated that WE-14 was evident in the limbo-corneal nerve
net at birth and that its detection parallels corneal development to adulthood, where WE-14 is
evident in a subpopulation of nerve ﬁbres. Microsc. Res. Tech. 62:408–414, 2003. © 2003 Wiley-Liss, Inc.
INTRODUCTION
The cornea forms the transparent dome at the front
of the eye; it covers the iris, pupil, and anterior cham-
ber and provides most of an eye’s optical power. It is
one of the most highly innervated external tissues in
the body, possessing both sensory and autonomic in-
nervation. Anatomical studies have revealed that the
density and pattern of corneal innervation is species
dependent (Zander and Weddell, 1951). A small num-
ber of sensory nerves contain the catecholamine syn-
thesising enzyme tyrosine hydroxylase (Ueda et al.,
1989), whilst a major population contains an array of
neuropeptides; substance P (SP) (Miller et al., 1981),
calcitonin gene-related peptide (CGRP) (Stone et al.,
1988a), galanin (Stone et al 1988b), and pituitary ade-
nylate cyclase-activating peptide (PACAP) (Moller et
al., 1993). Cornea sympathetic innervation contains
the classical neurotransmitters noradrenaline and se-
rotonin, and neuropeptide Y (NPY) (Marfurt, 2000).
Corneal parasympathetic innervation, which appears
limited, contains vasoactive intestinal polypeptide
(VIP), met-enkephalin, and NPY (Jones and Marfurt,
1998). Additional neuropeptides and pan-neuronal
markers detected include cholecystokinin (CCK)
(Palkama et al., 1986), vasopressin (Too et al., 1989),
brain natriuretic peptide (Yamamoto et al., 1991), neu-
rotensin (Tinsley et al., 1988), neurone-speciﬁc enolase
(NSE) (Ueda et al., 1989), and protein gene product
(PGP) 9.5 (Marfurt et al., 1993) have been detected in
corneal nerves.
Chromogranin A (CgA) is an established neuroendo-
crine marker; it is a member of the granin family of
acidic glycoproteins that are localised to dense cored
secretory granules in endocrine and neuronal cells
(Helle, 2000). Since its discovery, CgA has been cred-
ited with multiple physiological roles including granu-
logenesis (Gorr et al. 1989), modulation of intragranu-
lar calcium (Reiffen and Gratzl 1986), cell adhesion
(Gasparri et al. 1997), and CgA peptide fragments have
been reported to exhibit antibacterial and antifungal
properties (Lugardon et al., 2000). The cloning and
sequencing of CgA molecules revealed multiple pairs of
conserved basic residues that ﬂank homologous peptide
domains (Hutton et al., 1988); these features are char-
acteristic of prohormones. The identiﬁcation of the
CgA-derived peptides, vasostatin (Aardal and Helle,
1992), pancreastatin (PST) (Tatemoto et al., 1986),
WE-14 (Conlon et al., 1992; Curry et al., 1992), catosta-
tin (Mahata et al., 1997), and GE-25 (Kirchmair et al.,
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1994) further supports this biological role (Fig. 1).
WE-14 is ﬂanked by pairs of conserved basic residues
and exhibits a high degree of inter-species homology. It
is generated in a subpopulation of adult rat neuroen-
docrine cells (Curry et al., 1991) and to varying degrees
in human neuroendocrine neoplasia (Gleeson et al.,
1996; Heaney et al., 2000). Developmental studies have
shown that WE-14 is generated at an early stage of
endocrine gland generation in the rat and pig (Bar-
katullah et al., 1997, 2001) and that it has an ancient
lineage (Curry et al., 2002).
Studies have detected CgA in retinal neurons (Gib-
son and Munzo, 1993; Nolan et al. 1985) and a previous
study has revealed WE-14 is present in porcine retinal
cell populations and neurones innervating the anterior
uvea (Curry et al., 2003). This study employed a well-
characterised WE-14 antiserum to investigate its dis-
tribution in foetal, neonatal, and adult mouse sclero-
limbo-corneal tissues (Fig. 1).
MATERIALS AND METHODS
Embryonic (E17), neonatal (N0-N16), and adult
(6 weeks old) C57 mice housed under standard labora-
tory conditions (12:12 hour light-dark; fed and watered
ad libitum) were killed by CO2 asphyxiation. Intact
E17 heads and dissected corneo-scleral preparations
(N0-adult) were immersion ﬁxed in buffered 4% (w/v)
paraformaldehyde (PFA) in 0.1 M phosphate buffered
saline (PBS) pH 7.2 (4 hours, 4°C). Intact E17 heads
(n 4) were laterally bisected and intact corneo-scleral
specimens (n  4 per age; N0-adult) were placed in
incubation buffer (0.1 M PBS containing 0.3% (v/v)
Triton X100, 0.3% (w/v) bovine serum albumin, and
0.1% (w/v) sodium azide) for 48 hours, followed by
preincubation with non-immune goat serum (1:100,
24 hours) in incubation buffer and washed (18 hours)
with incubation buffer. The tissues were incubated (1:
200, 48 hours, 4°C) with a C-terminal speciﬁc WE-14
antiserum (R635) (Curry et al. 1991) (Fig. 1); washed in
incubation buffer (48 hours), incubated with porcine
anti-rabbit (FITC) secondary antiserum (1:200,
48 hours) (DAKO, Denmark) and washed (48 hours) in
incubation buffer. Intact tissue specimens were incu-
bated with propidium iodide (5 g/ml; 30 minutes)
followed by multiple washes for 24 hours with incuba-
tion buffer. All protocols were performed at 4°C with
constant gentle agitation in a dark chamber. Maltese
cross corneo-scleral specimens were prepared prior to
mounting in 90% (v/v) glycerol in 0.1 M PBS containing
anti-fade reagent (1,4-diazobicyclo(2,2,2)octane). Spec-
imens were viewed using a Bio-Rad microradiance con-
focal scanning laser microscope. Immunocytochemical
control studies were performed using 4% (w/v) PFA
ﬁxed cryoprotected adult tissue sections (30 m). This
included the liquid phase preabsorption of the WE-14
antiserum with synthetic human WE-14 and the C-
terminal hexapeptide antigen (Y°KELTAE) as de-
scribed previously (Barkatullah et al. 1997, 2001;
Norlen et al., 2001) and replacement of the primary
antiserum with non-immune rabbit serum and the
omission of the ﬂuorescein isothiocynate tagged swine
anti-rabbit sera. Unless otherwise stated, all chemicals
were purchased from Sigma Chemical Company, Poole,
UK.
RESULTS
WE-14 immunostaining was detected in nerve ﬁbres
of the developing and adult mouse limbo-corneal nerve
net (Figs. 2–4). Immunocytochemical control studies
demonstrated that WE-14 immunostaining was abol-
ished by preincubation of the C-terminal serum with
both the speciﬁc antigen (Y°KELTAE; 3.5 nM) and
human WE-14 (1 nM). No immunostaining was ob-
served following the inclusion of non-immune rabbit
serum and with the omission of the porcine anti-rabbit
FITC.
No WE-14 immunostaining was observed in the cor-
nea in situ within intact eyes of bisected head tissue at
E17. All subsequent observations were generated fol-
lowing confocal scanning laser microscopic (CLSM)
analysis of whole mount corneo-scleral tissues. At
N0/1, diffuse weak to moderate WE-14 immunostain-
ing was observed in a population of peripheral nerve
ﬁbre bundles entering from the limbo-scleral junction
of the developing cornea in a mid-stromal zone (Fig.
2a). At N3, moderately intense WE-14 immunoreactiv-
ity was detected in large mid-stromal nerve ﬁbre bun-
dles extending from the limbo-corneal junction toward
the central cornea (Fig. 2b). By N5, nerve ﬁbre tracts
derived from the mid-stromal plexus extended toward
the developing corneal epithelium, terminating in var-
icose ﬁbres within the basal zone of the corneal epi-
thelia (Fig. 2c). A similar pattern of WE-14 immuno-
staining was observed in the developing cornea at N7;
however, additional WE-14 immunoreactivity was ob-
served in a rudimentary scleral-limbo-corneal nerve
net (Fig. 2d). At N11, the cornea had developed a dis-
tinct stratiﬁed nerve net comparable to that of the
adult. This was composed of a network of thick mid-
stromal nerve tracts (Fig. 2e) that gave rise to an upper
stromal nerve net composed of ﬁne nerve tracts that
extended into the developing corneal epithelium; all
these nerve tracts possessed populations of varicose
WE-14 immunopositive ﬁbres. By N16 WE-14, immu-
nostaining was observed in an extensive ramifying var-
icose ﬁbre network beneath the limbo-corneal epithe-
lium. Some ﬁbres exhibited a close association with
unidentiﬁed superﬁcial limbal vessels that encircled
the corneal (Fig. 2f). The pattern and intensity of
WE-14 immunostaining in limbo-corneal nerves at N16
was comparable to that observed in adult mouse (Fig.
3a).
CSLM analysis of adult limbo-corneal preparations
revealed the extent of WE-14 immunostaining (Figs.
Fig. 1. Diagrammatic representation of murine and rat chromo-
granin A with the conserved pairs of basic residues above the location
of the derived peptides B-granin, pancreastatin (PST), catostatin
(CST), GE-25, and WE-14 with its single letter amino acid sequence
and inter-species homology, the C-terminal hexapeptide antigen
(line), and antibody code (R635).
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Fig. 2. Confocal scanning laser microscope Z-series images of WE-14
immunostaining in whole-mount preparation of the developing mouse
limbo-corneal nerve net (green) with propidium iodide nuclear
counter stain (red) (a–f). Each image represents a composite CSLM Z
series image generated from the following total section thickness: a,
65.1; b, 46.6; c, 22.2; d, 26.0; e, 6.1; f, 12.8 m, respectively. Weak
diffuse immunostaining in nerve ﬁbre tracts enters the cornea from
the limbo-scleral junction (arrowhead) at N0 (a). Moderately intense
varicose immunostaining in mid-stromal ﬁbres in the developing cen-
tral cornea at N3 (arrowhead) (b). Intense immunostaining in thin
nerve ﬁbre tracts (arrowhead) entering the basal epithelial cells (III);
these ﬁbres bifurcate to generate varicose ﬁbres that ramify amongst
the basal layer of the developing corneal epithelium (II) and terminate
amongst superﬁcial epithelial cells (I) at N5 (c). Intense neuronal
WE-14 immunostaining in the developing sub epithelial limbo-corneal
nerve (star) net at N7 (d). Characteristic intense varicose WE-14
immunostaining of ﬁbres within a prominent mid-stromal nerve ﬁbre
tract (arrowhead) (e) and in individual nerve ﬁbres in close associa-
tion with unidentiﬁed sub epithelial limbal vessels (arrowhead) at
N11 (f). Scale bar  20 m. [Color ﬁgure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
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Fig. 3. Confocal scanning laser microscope Z-series images of WE-14
immunostaining of whole-mount preparation in the adult mouse lim-
bo-corneal nerve net (green) with propidium iodide nuclear counter
stain (red) (a–f). Each image represents a composite of CSLM Z series
images generated from the following total section thickness; a, 9.1; b,
18.2; c, 3.2; d, 6.7; e, 17.0; f, 5.1 m, respectively. Low-magniﬁcation
image revealing the pattern of immunostaining in the limbo-corneal
nerve net; the white line corresponds to the limbo-scleral junction
with the major peripheral mid-stromal nerve ﬁbre tracts that enter
the cornea (arrowhead) from the limbus (a). Intense immunostaining
in nerve ﬁbres associated with unidentiﬁed superﬁcial vessels (star)
in the limbo-corneal junction (b). Varicose immunostaining localised
to ﬁbres in peripheral large mid-stromal ﬁbre tracts (large arrowhead)
and in minor ﬁbre tracts passing toward (small arrowhead) (c), and
forming the upper-stromal nerve tracts in the central cornea (small
arrowhead) (d). A leash in the basal central corneal epithelium (Bow-
man’s membrane: star) (e) and the corresponding (f) nerve ﬁbres
ramifying amongst squamous epithelium. Scale bar (a) 50 m, (b–f)
20 m. [Color ﬁgure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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3a–f and 4). WE-14 immunostaining was evident in a
sub-epithelial network of ﬁbres in the limbo-corneal
zone (Fig. 3a and b). Immunoreactivity was observed in
peripheral prominent mid-stromal nerve ﬁbre tracts
that project toward the central cornea (Fig. 3c).
Branches from these primary ﬁbre tracts extend to-
ward the upper stroma (Fig. 3c and d) forming a diffuse
irregular network beneath Bruch’s membrane (Fig.
3d); these latterly generate leashes in the basal epithe-
lium (Fig. 3e). Individual varicose WE-14 immunoposi-
tive ﬁbres were observed between the basal corneal
epithelium and some of these nerve ﬁbres terminated
amongst the outer-most corneal epithelial cells (Fig.
3f). An overview of the pattern of mid to upper stromal
WE-14 immunostaining in a tissue segment represent-
ing approximately a one-eighth area of cornea from the
limbo-corneal junction to the central cornea was gen-
erated from six contiguous CLMS images (Fig. 4).
DISCUSSION
The complexity of peptidergic limbo-corneal innerva-
tion is evident, yet the biological role for these familiar
Fig. 4. A composite image of six contiguous confocal scanning laser
microscope Z-series images of WE-14 immunostaining in a whole-
mount preparation of adult mouse limbo-corneal nerve net (green)
with propidium iodide nuclear counter stained (red). This image is
representative of WE-14 immunostaining in a corneal segment (ap-
proximately one-eighth) in the mid to upper stromus from the limbo-
corneal nerve net (star) to the central cornea adjacent to the scale bar
(100 m). The large ﬁbre tracts that enter the mid-stromal region
(large arrowhead) branch to form the upper stromal (small arrow-
head) network, which gives rise to ﬁne ﬁbres (small arrows) that form
leashes. A limited population of nerve ﬁbres (large arrow) entered the
peripheral cornea from the limbo-corneal network (star). (Mean sec-
tion thickness 33.9  8.3 m). [Color ﬁgure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]
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neuropeptides in this tissue is either inadequately de-
ﬁned or unknown (Marfurt, 2000). A previous study of
adult porcine ocular tissue revealed that another neu-
ropeptide WE-14 is generated in neuronal elements
primarily within the anterior uvea and retina (Curry et
al., 2003). This study of the developing mouse cornea
has demonstrated that immunoreactivity for WE-14
was present in a subpopulation of ﬁbres within the
major mid-stromal and minor upper stromal nerve ﬁ-
bre tracts and in ﬁne varicose ﬁbres throughout the
corneal epithelium. Several biological functions have
been attributed to corneal neuropeptides; these include
sensory perception and involvement in corneal epithe-
lial regeneration. Additionally, the detection of neu-
ropeptides adjacent to the limbal vasculature has led to
the suggestion that they may be vasomodulators (Jones
and Marfurt, 1998). The vasostatins represent candi-
date CgA-derived neuropeptides that may impact the
local vasculature (Aardal and Helle, 1992). The distri-
bution of WE-14 immunoreactivity observed in adult
mouse limbo-cornea preparations was comparable to
that of other neuropeptides. Therefore, it may exhibit
comparable biological roles. However, the relatively
sparse pattern of WE-14 immunostaining within ﬁbre
tracts relative to that reported for SP, NPY, CGRP, and
galanin (Jones and Marfurt, 1998) would suggest that
it is generated in a distinct type of neuron. The present
study has not established if WE-14 or other CgA-de-
rived peptides are generated in either sensory or auto-
nomic nerves; determination of this parameter may
offer some insight into their physiological role in cor-
neal tissue.
Analysis of the developing rat cornea detected SP
immunostaining at gestational day 17 (Sakiyama et al.
1984) and a dense CGRP corneal plexus was detected
at birth (Jones and Marfurt, 1991). This contrasts with
the weak diffuse WE-14 immunostaining detected in
peripheral mid stromal nerve tracts in the mouse cor-
nea at birth. A temporal pattern of WE-14 generation
was detected in the developing rat neuroendocrine sys-
tem. It was ﬁrst observed in endocrine cells in the
pancreas and stomach at E15.5, intestinal and chro-
mafﬁn cells at E17.5, and in thyroid parafollicular cells
at E18.5 (Barkatullah et al. 1997). The failure to detect
WE-14 in neonatal limbo-corneal nerves would suggest
that unlike SP and CGRP (Jones and Marfurt, 1991), it
does not have a biological role in early corneal devel-
opment.
The biological roles of diverse spectrum of neuropep-
tides in corneal pathophysiology are actively being
sought. SP and CGRP receptors have been detected on
limbal and corneal epithelial cells and increasing evi-
dence suggests that some neuropeptides exhibit trophic
functions (Heino et al. 1995; Kieselbach et al. 1990).
Supporting evidence has been derived following capsa-
icin administration, which depletes corneal neuropep-
tide content, limiting corneal healing (Gallar et al.
1990). Studies thus far have revealed that WE-14 mod-
ulates mast cell histamine secretion (Forsythe et al.
1996). The detection of WE-14 in the cornea has further
demonstrated the complexity of corneal innervation
and studies are underway to assess the physiological
role of WE-14 on corneal tissues.
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